Global Scans · Illness · Weekly Summary

• [New] By 2030, artificial intelligence is projected to shift healthcare's focus from disease treatment to proactive prevention. Briefs Finance
• [New] Someone with less than a 3% chance of developing cardiovascular disease over the next 10 years may still be considered for a statin if their estimated 30-year risk is at least 10%. CNN
• A pioneering experimental treatment for motor neurone disease, developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme. UCL News
• Deaths from Alzheimer's disease have more than doubled since 2000, and the number of people affected is expected to nearly double by 2060. Southcoast Health
• By disease type, the cardiovascular diseases segment is anticipated to grow at the highest CAGR during the forecast period of 2026 to 2035. Precedence Research
• Wegovy offers adults with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events such as death, heart attack, or stroke in adults with obesity with known heart disease - making Wegovy pill truly distinct. BioSpace
• The majority of the adult population 50 years and older, across all races, will have at least one chronic disease by 2050, with the majority between the ages of 60 to 79 years. PubMed Central (PMC)
• One in four Singaporeans could be living with chronic kidney disease by 2035. ST
• North Carolina continues to receive federal support through entities such as the CDC's Epidemiology and Laboratory Capacity Program, which helps strengthen laboratory systems and detect infectious disease threats. WRAL
• Fastest-growing Region: Asia Pacific is projected to be the fastest-growing, driven by expanding healthcare infrastructure, rising surgical volumes, broader insurance coverage, and increasing chronic disease-related wound care demand. Persistence Market Research
• The 40-59 years category will have the highest CAGR, due to an increased incidence of wet AMD in younger populations with earlier onset neovascularization related to genetic predispositions, inflammatory pathways and modifiable risk factors such as smoking, obesity and cardiovascular disease. P&S Intelligence

Last updated: 16 August 2026